Tag: ADA
ADA: Novo Nordisk’s long-lasting insulin candidate matches Lantus in phase 2
Novo Nordisk has long been working on drugs that can help people earlier on in their diabetes and keep them from progressing to insulin...
ADA: Sanofi bolsters Soliqua with real-world data showing starting insulin, GLP-1...
Sanofi’s Soliqua combines an insulin with a GLP-1 agonist, and according to a new real-world study, delivering those two therapies simultaneously is the way...